Park Ha Biological Technology Co., Ltd. is trading at $1.30 (-12.18%) in pre-market following a sharp overnight drop. This decline appears to be a reaction to the closing of its $2.0 million registered direct offering on June 15, 2026. The offering, priced at $1.50 per unit, may be influencing investor sentiment as the stock currently trades below the offering price. The move appears isolated rather than market-wide, with major U.S. indexes only slightly mixed.